SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In
 
We’re going down soon, to move to a new Data Center today.  We’ll be up ASAP.  Sorry.

Neupert Peter M – ‘4’ for 3/12/24 re: Adaptive Biotechnologies Corp.

On:  Wednesday, 3/13/24, at 5:55pm ET   ·   For:  3/12/24   ·   As:  Director   ·   Accession #:  1062993-24-6350   ·   File #:  1-38957

Previous ‘4’:  ‘4’ on 3/6/24 for 3/4/24   ·   Latest ‘4’:  This Filing

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/13/24  Neupert Peter M                   4          Director    1:5K   Adaptive Biotechnologies Corp.    Newsfile Corp./FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      6K 
                Securities by an Insider -- form4.xml/5.8


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
XML Data rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<ownershipDocument>
<schemaVersion> X0508 </schemaVersion>
<documentType> 4 </documentType>
<periodOfReport> 2024-03-12 </periodOfReport>
<issuer>
<issuerCik> 0001478320 </issuerCik>
<issuerName> Adaptive Biotechnologies Corp </issuerName>
<issuerTradingSymbol> ADPT </issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik> 0001237566 </rptOwnerCik>
<rptOwnerName> NEUPERT PETER M </rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerStreet1> C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION </rptOwnerStreet1>
<rptOwnerStreet2> 1165 EASTLAKE AVENUE EAST </rptOwnerStreet2>
<rptOwnerCity> SEATTLE </rptOwnerCity>
<rptOwnerState> WA </rptOwnerState>
<rptOwnerZipCode> 98109 </rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector> 1 </isDirector>
<isOfficer> 0 </isOfficer>
<isTenPercentOwner> 0 </isTenPercentOwner>
<isOther> 0 </isOther>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One> 0 </aff10b5One>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value> Common Stock </value>
</securityTitle>
<transactionDate>
<value> 2024-03-12 </value>
</transactionDate>
<transactionCoding>
<transactionFormType> 4 </transactionFormType>
<transactionCode> M </transactionCode>
<equitySwapInvolved> 0 </equitySwapInvolved>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value> 15000 </value>
</transactionShares>
<transactionPricePerShare>
<value> 0.84 </value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value> A </value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 169296 </value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<derivativeTable>
<derivativeTransaction>
<securityTitle>
<value> Stock Option (right to buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> .84 </value>
</conversionOrExercisePrice>
<transactionDate>
<value> 2024-03-12 </value>
</transactionDate>
<transactionCoding>
<transactionFormType> 4 </transactionFormType>
<transactionCode> M </transactionCode>
<equitySwapInvolved> 0 </equitySwapInvolved>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value> 15000 </value>
</transactionShares>
<transactionPricePerShare>
<value> 0 </value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value> D </value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<exerciseDate>
<footnoteId id="F1"/>
</exerciseDate>
<expirationDate>
<value> 2024-03-13 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 15000 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 0 </value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeTransaction>
</derivativeTable>
<footnotes>
<footnote id="F1"> The option was fully vested as of January 1, 2015. </footnote>
</footnotes>
<ownerSignature>
<signatureName> /s/ Peter M Neupert by Stacy L Taylor, Attorney-in-Fact </signatureName>
<signatureDate> 2024-03-13 </signatureDate>
</ownerSignature>
</ownershipDocument>


↑Top
Filing Submission 0001062993-24-006350   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., May 11, 8:04:47.2am ET